MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2026.116969

Медицинская библиотека · International immunopharmacology · 2026

Methotrexate inhibits the TEL-JAK2-STAT pathway through a folate metabolism-dependent mechanism in Ba/F3 cells.

Saito Masaya, Takeda Kengo, Yoshino Misato, Ichikawa Daiju, Ohta Satoshi, Nakazawa Yosuke, Tago Kenji, Funakoshi-Tago Megumi

СтатьяПеревод в очереди

Аннотация

Methotrexate (MTX) is a folate antagonist that inhibits dihydrofolate reductase (DHFR), thereby depleting intracellular reduced folate pools. Previous studies have reported that MTX suppresses the JAK-STAT signaling pathway; however, the contribution of folate antagonism to this effect versus potential direct kinase inhibition remains poorly understood. In this study, we investigated the effects of MTX on the signaling activity of TEL-JAK2, a constitutively active fusion protein associated with T-cell acute lymphoblastic leukemia. Ba/F3 cells expressing TEL-JAK2 were treated with MTX or 5-fluorouracil (5-FU), a DNA synthesis inhibitor that targets thymidylate synthase without depleting the upstream folate pool. Both agents effectively reduced cell proliferation and viability while inducing apoptosis. Notably, MTX suppressed the phosphorylation of TEL-JAK2 and its downstream effectors, STAT3 and STAT5. The MTX-induced suppression of the TEL-JAK2-STAT axis was fully reversed by supplementation with folinic acid. Furthermore, genetic ablation of DHFR using CRISPR/Cas9 recapitulated these effects, whereas overexpression of DHFR attenuated MTX-induced apoptosis and suppression of the TEL-JAK2-STAT axis, confirming that disruption of folate metabolism leads to the suppression of the TEL-JAK2-STAT axis. In contrast, 5-FU had no effect on the phosphorylation of TEL-JAK2, STAT3, or STAT5, indicating that the inhibition is not a secondary consequence of DNA synthesis impairment. These findings demonstrate that MTX inhibits the TEL-JAK2-STAT pathway through a folate-dependent mechanism, revealing a novel link between folate metabolism and oncogenic JAK-STAT signaling.

Для цитирования: Saito Masaya, Takeda Kengo, Yoshino Misato, Ichikawa Daiju, Ohta Satoshi, Nakazawa Yosuke, Tago Kenji, Funakoshi-Tago Megumi. Methotrexate inhibits the TEL-JAK2-STAT pathway through a folate metabolism-dependent mechanism in Ba/F3 cells.. International immunopharmacology. 2026. DOI: 10.1016/j.intimp.2026.116969.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.